Over the last 12 months, Phibro Animal Health insiders reported 1 buy totaling $318K and 36 sales totaling $32.0M across SEC Form 4 filings. 97% of those filings were made under pre-arranged 10b5-1 trading plans.
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | CORCORAN E THOMASD | ▲ Buy | 10,000 | $31.77 | $318K | +31.8% | — |
| May 7, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 18,608 | $54.61 | $1.0M | -24.9% | plan · 7 tranches · indirect |
| Apr 30, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 21,120 | $53.86 | $1.1M | -22% | plan · 7 tranches · indirect |
| Apr 23, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 21,120 | $54.79 | $1.2M | -18.1% | plan · 5 tranches · indirect |
| Apr 16, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 21,120 | $56.89 | $1.2M | -15.3% | plan · 7 tranches · indirect |
| Mar 31, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 14,080 | $53.75 | $757K | -27% | plan · 4 tranches · indirect |
| Mar 26, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 21,120 | $55.21 | $1.2M | -28.8% | plan · 7 tranches · indirect |
| Mar 19, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 22,880 | $52.4 | $1.2M | -23.8% | plan · 7 tranches · indirect |
| Mar 13, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 5,280 | $48.91 | $258K | -5.2% | plan · indirect |
| Feb 26, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 21,120 | $52.27 | $1.1M | -93.5% | plan · 5 tranches · indirect |
| Feb 20, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 14,080 | $50.84 | $716K | -38.4% | plan · 3 tranches · indirect |
| Feb 18, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 14,080 | $51.68 | $728K | -27.7% | plan · 3 tranches · indirect |
| Feb 11, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 72,198 | $51.77 | $3.7M | -58.7% | plan · 4 tranches · indirect |
| Feb 5, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 110,842 | $48.38 | $5.4M | -47.4% | plan · 6 tranches · indirect |
| Feb 4, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 13,180 | $41.39 | $545K | -21.3% | plan · 3 tranches · indirect |
| Jan 30, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 13,465 | $40.11 | $540K | -29.6% | plan · 2 tranches · indirect |
| Jan 23, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 1,235 | $40.55 | $50K | -7.4% | plan · indirect |
| Jan 22, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 27,845 | $41.82 | $1.2M | -62.5% | plan · 3 tranches · indirect |
| Jan 15, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 14,134 | $40.31 | $570K | -24.1% | plan · 4 tranches · indirect |
| Jan 9, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 213 | $40.16 | $9K | -0.5% | plan · indirect |
| Jan 7, 2026 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 328 | $40.09 | $13K | -0.8% | plan · indirect |
| Dec 11, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 5,752 | $40.93 | $235K | -12.8% | plan · 2 tranches · indirect |
| Dec 9, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 4,808 | $40.1 | $193K | -9.7% | plan · 2 tranches · indirect |
| Dec 4, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 7,040 | $41 | $289K | -12.4% | plan · 3 tranches · indirect |
| Dec 1, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 7,040 | $42.1 | $296K | -20.8% | plan · 2 tranches · indirect |
| Nov 26, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 12,320 | $43.97 | $542K | -26.7% | plan · 2 tranches · indirect |
| Nov 20, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 3,520 | $41.76 | $147K | -7.1% | plan · 2 tranches · indirect |
| Nov 18, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 10,560 | $44.19 | $467K | -17.5% | plan · 3 tranches · indirect |
| Nov 13, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 30,337 | $45.01 | $1.4M | -85.3% | plan · 3 tranches · indirect |
| Nov 10, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 41,823 | $45.09 | $1.9M | -67% | plan · 5 tranches · indirect |
| Nov 5, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 7,040 | $42.16 | $297K | -10.1% | plan · 4 tranches · indirect |
| Oct 30, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 10,560 | $41.43 | $437K | -19.2% | plan · 3 tranches · indirect |
| Oct 24, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 18,899 | $40.53 | $766K | -25.6% | plan · 3 tranches · indirect |
| Oct 20, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 16,775 | $40.37 | $677K | -41.2% | plan · 2 tranches · indirect |
| Sep 30, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 20,664 | $40.38 | $834K | -33.7% | plan · indirect |
| Sep 18, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 7,022 | $40.26 | $283K | -18.3% | plan · indirect |
| Sep 11, 2025 | BENDHEIM JACKPresident and CEO · O·D·10% | ▼ Sale | 21,120 | $40.59 | $857K | -35.5% | plan · 3 tranches · indirect |
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Phibro Animal Health filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $PAHC feed.